These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8804007)

  • 1. High flux dialysis membranes improve plasma lipoprotein profiles in patients with end-stage renal disease.
    Goldberg IJ; Kaufman AM; Lavarias VA; Vanni-Reyes T; Levin NW
    Nephrol Dial Transplant; 1996; 11 Suppl 2():104-7. PubMed ID: 8804007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins--a cross-over trial.
    Ingram AJ; Parbtani A; Churchill DN
    Nephrol Dial Transplant; 1998 Jun; 13(6):1452-7. PubMed ID: 9641175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of plasma lipoprotein profiles during high-flux dialysis.
    Seres DS; Strain GW; Hashim SA; Goldberg IJ; Levin NW
    J Am Soc Nephrol; 1993 Jan; 3(7):1409-15. PubMed ID: 8439653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein metabolism in normal and uremic patients.
    Goldberg IJ
    Am J Kidney Dis; 1993 Jan; 21(1):87-90. PubMed ID: 8418633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodialysis using high flux membranes improves lipid profiles.
    Blankestijn PJ
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S48-51. PubMed ID: 7923984
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
    Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperlipidemia of chronic renal failure.
    Kaysen GA
    Blood Purif; 1994; 12(1):60-7. PubMed ID: 7986478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-flux dialyzers, backfiltration, and dialysis fluid quality.
    Schiffl H
    Semin Dial; 2011; 24(1):1-4. PubMed ID: 21299628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial.
    Chazot C; Kirchgessner J; Pham J; Vo-Van C; Lorriaux C; Hurot JM; Zaoui E; Grassmann A; Jean G; Marcelli D
    Nephron; 2015; 129(4):269-75. PubMed ID: 25825336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.
    Donadio C; Tognotti D; Caponi L; Paolicchi A
    BMC Nephrol; 2017 Feb; 18(1):68. PubMed ID: 28219328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin induces an accumulation of atherogenic lipoproteins during hemodialysis in normolipidemic end-stage renal disease patients.
    Barbagallo CM; Noto D; Cefalù AB; Ganci A; Giammarresi C; Panno D; Cusumano G; Greco M; Di Gaudio F; Averna MR
    Hemodial Int; 2015 Jul; 19(3):360-7. PubMed ID: 25495659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Washout of water-soluble vitamins and of homocysteine during haemodialysis: effect of high-flux and low-flux dialyser membranes.
    Heinz J; Domröse U; Westphal S; Luley C; Neumann KH; Dierkes J
    Nephrology (Carlton); 2008 Oct; 13(5):384-9. PubMed ID: 18518942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study.
    Diop ME; Viron B; Bailleul S; Lefevre G; Fessi H; Maury J; Etienne J; Couderc R
    Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.